Clearside Biomedical, Inc. Human Resources Contracts & Agreements
25 Contracts & Agreements
- Bonus & Incentive Agreements (7 contracts)
- Compensation Agreements (5)
- Consulting Agreements (2)
- Employment Agreements (9)
- Separation Agreements (2)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 10, 2024)
- First Amendment to Consulting Agreement, by and between Registrant and Thomas Ciulla, dated as of February 17, 2024 (Filed With SEC on March 12, 2024)
- Fourth Amended and Restated Non-employee Director Compensation Policy (Filed With SEC on August 12, 2022)
- Third Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 11, 2022)
- Executive Employment Agreement, by and between Clearside Biomedical, Inc. and Thomas Ciulla, dated as of June 24, 2019 (Filed With SEC on August 10, 2020)
- Amended and Restated Executive Employment Agreement, dated March 11, 2020, by and between the Company and George Lasezkay (Filed With SEC on March 16, 2020)
- Consulting and Independent Contractor Agreement, by and between the Registrant and Brion Raymond, dated as of January 3, 2020 (Filed With SEC on March 13, 2020)
- Separation Agreement, by and between the Registrant and Brion Raymond, dated as of January 3, 2020 (Filed With SEC on March 13, 2020)
- Separation Agreement, by and between the Registrant and Daniel White, dated as of April 7, 2019 (Filed With SEC on March 13, 2020)
- Executive Employment Agreement, by and between the Company and Brion S. Raymond, dated as of February 20, 2018 (Filed With SEC on March 15, 2019)
- Change in Control Equity Acceleration Plan, amending the Registrants 2016 Equity Incentive Plan (Filed With SEC on August 8, 2018)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 9, 2017)
- Amended and Restated Executive Employment Agreement, by and between Clearside Biomedical, Inc. and Glenn Noronha, dated as of August 3, 2017 (Filed With SEC on November 9, 2017)
- Amended and Restated Executive Employment Agreement, by and between Clearside Biomedical, Inc. and Charles A. Deignan, dated as of August 3, 2017 (Filed With SEC on November 9, 2017)
- Amended and Restated Executive Employment Agreement, by and between Clearside Biomedical, Inc. and Daniel H. White, dated as of August 3, 2017 (Filed With SEC on November 9, 2017)
- CLEARSIDE BIOMEDICAL, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 18, 2016)
- CLEARSIDE BIOMEDICAL, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2016 EQUITY INCENTIVE PLAN) (Filed With SEC on March 18, 2016)
- CLEARSIDE BIOMEDICAL, INC. STOCK OPTION GRANT NOTICE (2016 EQUITY INCENTIVE PLAN) (Filed With SEC on March 18, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on January 8, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on January 8, 2016)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on January 8, 2016)
- CLEARSIDE BIOMEDICAL, INC. NOTICE OF NONSTATUTORY STOCK OPTION 2011 STOCK INCENTIVE PLAN (Filed With SEC on January 8, 2016)
- CLEARSIDE BIOMEDICAL, INC. NOTICE OF INCENTIVE STOCK OPTION 2011 STOCK INCENTIVE PLAN (Filed With SEC on January 8, 2016)
- CLEARSIDE BIOMEDICAL, INC. 2011 STOCK INCENTIVE PLAN (Filed With SEC on January 8, 2016)
- CLEARSIDE BIOMEDICAL, INC. 2016 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 21, 2016 APPROVED BY THE STOCKHOLDERS:[ ], 2016 IPO DATE/EFFECTIVEDATE: [ ], 2016 (Filed With SEC on March 18, 2016)
